1. Which of these is not one of the core requirements for an organization working to gain commitment to large-scale change Please, consider that that a Kd refers to an equilibrium. This seemingly easy question may require a full page of analysis if you do a decent job! a. It is just a matter of the strength of H-bonds, with making the strongest ones, then esters, then ketones. b. Ligands 1 and 3 are rigid, while ligand 2 shows flexibility around the ester bond. Therefore, ligands 1 and 3 are about equally strong, and 2 is almost 1000-fold weaker. c.There is no rational explanation. d. It is a balance between hydrogen bond formation and solvation. Amides form strong H-bonds, esters decent ones, ketones yet weaker ones. Also we need to take into consideration the nature of the receptor. There is a cost to desolvate the amide and the ester, an little cost to desolvate the ketone. e. It is a balance between hydrogen bond formation and solvation. Amides and esters form strong H-bonds, ketones not. There is no cost to desolvate the amide, a large penalty to desolvate the ester, an little cost to desolvate the ketone.
18. The easiest way to gain a lot of affinity of a ligand in drug design is: a. To introduce a double bond to reduce the conformational entropy. b. To introduce a salt bridge as Coulomb's law says that the energy of interactions between opposite charges is very large. c. To add a hydrophobic substituent to gain affinity by the hydrophobic effect. d. To make a symmetrical molecule to reduce the rotational entropy upon binding. e. To introduce a new hydrogen bond.
